Asthma and allergy: Short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the “Asthma–Allergy” association

Summary The Asthma Plan published by the French Health Ministry in 2002, the experts conferences edited by ANAES on therapeutic education and follow-up of asthma, the inclusion of this disease in the Public Health Law have been remarkable steps in France during the last few years. The medical commun...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2008-10, Vol.102 (10), p.1483-1493
Hauptverfasser: Tillie-Leblond, Isabelle, Magnan, Antoine, Pauli, Gabrielle, Vervloet, Daniel, Wallaert, Benoît, Didier, Alain, Ameille, Jacques, Godard, Philippe, the group of experts
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1493
container_issue 10
container_start_page 1483
container_title Respiratory medicine
container_volume 102
creator Tillie-Leblond, Isabelle
Magnan, Antoine
Pauli, Gabrielle
Vervloet, Daniel
Wallaert, Benoît
Didier, Alain
Ameille, Jacques
Godard, Philippe
the group of experts
description Summary The Asthma Plan published by the French Health Ministry in 2002, the experts conferences edited by ANAES on therapeutic education and follow-up of asthma, the inclusion of this disease in the Public Health Law have been remarkable steps in France during the last few years. The medical community, more particularly the pneumological community, has shown its commitment in the treatment of this public health problem. But allergy was not sufficiently taken into account, although it is responsible for nearly 50 to 60% cases of asthma. In most so-called developed countries the prevalence of asthma and of allergies has increased in the last twenty years. Its progress varies according to country and age group: the increased prevalence of allergy, more specifically of rhinitis and eczema, is most marked in children aged 6-7 year. The prevalence of asthma seems to have reached a plateau in certain northern countries or seems to have decreased in 13-14 year olds (Anglo-Saxon countries). There were multiple reasons, generally attributed to changes in life-style. Asthma is the result of an interaction between a genetic predisposition and the environment, where allergens are present, but also smoking. The relationships between allergy and asthma are complex. This conference discussed the various essential issues that face doctors who treat patients with asthma in their daily practice. The risk factors, the methods of exploration in children and adults and the specific treatments are, indeed, essential issues to be evaluated in a frequent pathology that interests a large number of physicians. The variety of experts is wide, representing pneumology (French Speaking Pneumology Society), the occupational medicine world (FrenchSociety of Occupational Medicine), the allergic pathology (French Society of Allergology and Clinical Immunology), and patients with the patient association “Asthma & Allergy”, physicians belonging to the general medicine community, general hospitals, private hospitals and academic hospitals in France.The proposed guidelines are aimed at helping practitioners in distinguishing what is established from what remains to be demonstrated and/or assessed with respect to the different modalities for the exploration or treatment of allergic asthma.
doi_str_mv 10.1016/j.rmed.2008.03.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1035157235</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S095461110800098X</els_id><sourcerecordid>2745719621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-d82de4ad711eb9c2de4ad0bbe92406f922ce1b77d68f45b7cc711f8962de5cb63</originalsourceid><addsrcrecordid>eNp9kt-K1DAUxqso7rj6Al5IYBF2wRmT_ptWRBgGRwdm2YWu4F1I09NtZtukJq1u7-YdvNWXmycxndYVRbwKyfl9X05OPsd5RvCMYBK-2s50BdnMxTiaYW-GsXvfmZDAc6ceDv0HzgTHgT8NCSFHzmNjthjj2PfxI-eIRKGPI3c-uectTFNUDDGZIVaWoK-71ygplG5QA7eNORQ0cFVVIDPWCCUNUjlqCkBwW4PluJI5aJAcfhVW_a5ASQ3sRshrdCmhrVSprjuUKC6g6dBpcrlZnb1EQqKa6UaCNoWo0VfRFH9YjLg1Xhy6G1z6ppalkIKzEq2rqpXD-WmyWqyX1vbfFhect_XhDVZ2DpngQkIvOr86O3j2sv3u-zCT_e7bcGe33_1AzBhrdBA_cR7mrDTwdFyPnY-rd1fLD9PNxfv1crGZ8oCQZppFbgY-y-aEQBrzYYPTFGLXx2Eeuy4Hks7nWRjlfpDOObdkHsWhJQOeht6xczL41lp9bsE0dKtabXs3lGAvIMHc9QJLuQPFtTJGQ05rLSqmOwvRPid0S_uc0D4nFHvU5sSKno_WbdrX7iRjMCzwYgSYsUPONZNcmDvOxWEUksC33JuBAzuILwI0NXbcNguZsKlpaKbE__t4-5ecj996Ax2Y3--lxqWYJn2i-0DjqA9z9Mn7CfY59_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035157235</pqid></control><display><type>article</type><title>Asthma and allergy: Short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the “Asthma–Allergy” association</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via ScienceDirect (Elsevier)</source><creator>Tillie-Leblond, Isabelle ; Magnan, Antoine ; Pauli, Gabrielle ; Vervloet, Daniel ; Wallaert, Benoît ; Didier, Alain ; Ameille, Jacques ; Godard, Philippe ; the group of experts</creator><creatorcontrib>Tillie-Leblond, Isabelle ; Magnan, Antoine ; Pauli, Gabrielle ; Vervloet, Daniel ; Wallaert, Benoît ; Didier, Alain ; Ameille, Jacques ; Godard, Philippe ; the group of experts ; French Society of Allergology and Clinical Immunology ; French Speaking Pneumology Society ; Asthma-Allergy association ; French Society of Occupational Medicine</creatorcontrib><description>Summary The Asthma Plan published by the French Health Ministry in 2002, the experts conferences edited by ANAES on therapeutic education and follow-up of asthma, the inclusion of this disease in the Public Health Law have been remarkable steps in France during the last few years. The medical community, more particularly the pneumological community, has shown its commitment in the treatment of this public health problem. But allergy was not sufficiently taken into account, although it is responsible for nearly 50 to 60% cases of asthma. In most so-called developed countries the prevalence of asthma and of allergies has increased in the last twenty years. Its progress varies according to country and age group: the increased prevalence of allergy, more specifically of rhinitis and eczema, is most marked in children aged 6-7 year. The prevalence of asthma seems to have reached a plateau in certain northern countries or seems to have decreased in 13-14 year olds (Anglo-Saxon countries). There were multiple reasons, generally attributed to changes in life-style. Asthma is the result of an interaction between a genetic predisposition and the environment, where allergens are present, but also smoking. The relationships between allergy and asthma are complex. This conference discussed the various essential issues that face doctors who treat patients with asthma in their daily practice. The risk factors, the methods of exploration in children and adults and the specific treatments are, indeed, essential issues to be evaluated in a frequent pathology that interests a large number of physicians. The variety of experts is wide, representing pneumology (French Speaking Pneumology Society), the occupational medicine world (FrenchSociety of Occupational Medicine), the allergic pathology (French Society of Allergology and Clinical Immunology), and patients with the patient association “Asthma &amp; Allergy”, physicians belonging to the general medicine community, general hospitals, private hospitals and academic hospitals in France.The proposed guidelines are aimed at helping practitioners in distinguishing what is established from what remains to be demonstrated and/or assessed with respect to the different modalities for the exploration or treatment of allergic asthma.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2008.03.002</identifier><identifier>PMID: 18640827</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adult ; Allergy ; Anti-Allergic Agents - therapeutic use ; Anti-Asthmatic Agents - therapeutic use ; Asthma ; Asthma - drug therapy ; Asthma - immunology ; Biological and medical sciences ; Child ; Chronic obstructive pulmonary disease, asthma ; Exploration ; France ; Humans ; Hypersensitivity - drug therapy ; Hypersensitivity - immunology ; Medical sciences ; Occupational Medicine ; Pneumology ; Pulmonary Medicine ; Pulmonary/Respiratory ; Recommendations ; Tobacco Smoke Pollution</subject><ispartof>Respiratory medicine, 2008-10, Vol.102 (10), p.1483-1493</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-d82de4ad711eb9c2de4ad0bbe92406f922ce1b77d68f45b7cc711f8962de5cb63</citedby><cites>FETCH-LOGICAL-c511t-d82de4ad711eb9c2de4ad0bbe92406f922ce1b77d68f45b7cc711f8962de5cb63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rmed.2008.03.002$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20686154$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18640827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tillie-Leblond, Isabelle</creatorcontrib><creatorcontrib>Magnan, Antoine</creatorcontrib><creatorcontrib>Pauli, Gabrielle</creatorcontrib><creatorcontrib>Vervloet, Daniel</creatorcontrib><creatorcontrib>Wallaert, Benoît</creatorcontrib><creatorcontrib>Didier, Alain</creatorcontrib><creatorcontrib>Ameille, Jacques</creatorcontrib><creatorcontrib>Godard, Philippe</creatorcontrib><creatorcontrib>the group of experts</creatorcontrib><creatorcontrib>French Society of Allergology and Clinical Immunology</creatorcontrib><creatorcontrib>French Speaking Pneumology Society</creatorcontrib><creatorcontrib>Asthma-Allergy association</creatorcontrib><creatorcontrib>French Society of Occupational Medicine</creatorcontrib><title>Asthma and allergy: Short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the “Asthma–Allergy” association</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><description>Summary The Asthma Plan published by the French Health Ministry in 2002, the experts conferences edited by ANAES on therapeutic education and follow-up of asthma, the inclusion of this disease in the Public Health Law have been remarkable steps in France during the last few years. The medical community, more particularly the pneumological community, has shown its commitment in the treatment of this public health problem. But allergy was not sufficiently taken into account, although it is responsible for nearly 50 to 60% cases of asthma. In most so-called developed countries the prevalence of asthma and of allergies has increased in the last twenty years. Its progress varies according to country and age group: the increased prevalence of allergy, more specifically of rhinitis and eczema, is most marked in children aged 6-7 year. The prevalence of asthma seems to have reached a plateau in certain northern countries or seems to have decreased in 13-14 year olds (Anglo-Saxon countries). There were multiple reasons, generally attributed to changes in life-style. Asthma is the result of an interaction between a genetic predisposition and the environment, where allergens are present, but also smoking. The relationships between allergy and asthma are complex. This conference discussed the various essential issues that face doctors who treat patients with asthma in their daily practice. The risk factors, the methods of exploration in children and adults and the specific treatments are, indeed, essential issues to be evaluated in a frequent pathology that interests a large number of physicians. The variety of experts is wide, representing pneumology (French Speaking Pneumology Society), the occupational medicine world (FrenchSociety of Occupational Medicine), the allergic pathology (French Society of Allergology and Clinical Immunology), and patients with the patient association “Asthma &amp; Allergy”, physicians belonging to the general medicine community, general hospitals, private hospitals and academic hospitals in France.The proposed guidelines are aimed at helping practitioners in distinguishing what is established from what remains to be demonstrated and/or assessed with respect to the different modalities for the exploration or treatment of allergic asthma.</description><subject>Adult</subject><subject>Allergy</subject><subject>Anti-Allergic Agents - therapeutic use</subject><subject>Anti-Asthmatic Agents - therapeutic use</subject><subject>Asthma</subject><subject>Asthma - drug therapy</subject><subject>Asthma - immunology</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Exploration</subject><subject>France</subject><subject>Humans</subject><subject>Hypersensitivity - drug therapy</subject><subject>Hypersensitivity - immunology</subject><subject>Medical sciences</subject><subject>Occupational Medicine</subject><subject>Pneumology</subject><subject>Pulmonary Medicine</subject><subject>Pulmonary/Respiratory</subject><subject>Recommendations</subject><subject>Tobacco Smoke Pollution</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kt-K1DAUxqso7rj6Al5IYBF2wRmT_ptWRBgGRwdm2YWu4F1I09NtZtukJq1u7-YdvNWXmycxndYVRbwKyfl9X05OPsd5RvCMYBK-2s50BdnMxTiaYW-GsXvfmZDAc6ceDv0HzgTHgT8NCSFHzmNjthjj2PfxI-eIRKGPI3c-uectTFNUDDGZIVaWoK-71ygplG5QA7eNORQ0cFVVIDPWCCUNUjlqCkBwW4PluJI5aJAcfhVW_a5ASQ3sRshrdCmhrVSprjuUKC6g6dBpcrlZnb1EQqKa6UaCNoWo0VfRFH9YjLg1Xhy6G1z6ppalkIKzEq2rqpXD-WmyWqyX1vbfFhect_XhDVZ2DpngQkIvOr86O3j2sv3u-zCT_e7bcGe33_1AzBhrdBA_cR7mrDTwdFyPnY-rd1fLD9PNxfv1crGZ8oCQZppFbgY-y-aEQBrzYYPTFGLXx2Eeuy4Hks7nWRjlfpDOObdkHsWhJQOeht6xczL41lp9bsE0dKtabXs3lGAvIMHc9QJLuQPFtTJGQ05rLSqmOwvRPid0S_uc0D4nFHvU5sSKno_WbdrX7iRjMCzwYgSYsUPONZNcmDvOxWEUksC33JuBAzuILwI0NXbcNguZsKlpaKbE__t4-5ecj996Ax2Y3--lxqWYJn2i-0DjqA9z9Mn7CfY59_w</recordid><startdate>20081001</startdate><enddate>20081001</enddate><creator>Tillie-Leblond, Isabelle</creator><creator>Magnan, Antoine</creator><creator>Pauli, Gabrielle</creator><creator>Vervloet, Daniel</creator><creator>Wallaert, Benoît</creator><creator>Didier, Alain</creator><creator>Ameille, Jacques</creator><creator>Godard, Philippe</creator><creator>the group of experts</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope></search><sort><creationdate>20081001</creationdate><title>Asthma and allergy: Short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the “Asthma–Allergy” association</title><author>Tillie-Leblond, Isabelle ; Magnan, Antoine ; Pauli, Gabrielle ; Vervloet, Daniel ; Wallaert, Benoît ; Didier, Alain ; Ameille, Jacques ; Godard, Philippe ; the group of experts</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-d82de4ad711eb9c2de4ad0bbe92406f922ce1b77d68f45b7cc711f8962de5cb63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Allergy</topic><topic>Anti-Allergic Agents - therapeutic use</topic><topic>Anti-Asthmatic Agents - therapeutic use</topic><topic>Asthma</topic><topic>Asthma - drug therapy</topic><topic>Asthma - immunology</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Exploration</topic><topic>France</topic><topic>Humans</topic><topic>Hypersensitivity - drug therapy</topic><topic>Hypersensitivity - immunology</topic><topic>Medical sciences</topic><topic>Occupational Medicine</topic><topic>Pneumology</topic><topic>Pulmonary Medicine</topic><topic>Pulmonary/Respiratory</topic><topic>Recommendations</topic><topic>Tobacco Smoke Pollution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tillie-Leblond, Isabelle</creatorcontrib><creatorcontrib>Magnan, Antoine</creatorcontrib><creatorcontrib>Pauli, Gabrielle</creatorcontrib><creatorcontrib>Vervloet, Daniel</creatorcontrib><creatorcontrib>Wallaert, Benoît</creatorcontrib><creatorcontrib>Didier, Alain</creatorcontrib><creatorcontrib>Ameille, Jacques</creatorcontrib><creatorcontrib>Godard, Philippe</creatorcontrib><creatorcontrib>the group of experts</creatorcontrib><creatorcontrib>French Society of Allergology and Clinical Immunology</creatorcontrib><creatorcontrib>French Speaking Pneumology Society</creatorcontrib><creatorcontrib>Asthma-Allergy association</creatorcontrib><creatorcontrib>French Society of Occupational Medicine</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tillie-Leblond, Isabelle</au><au>Magnan, Antoine</au><au>Pauli, Gabrielle</au><au>Vervloet, Daniel</au><au>Wallaert, Benoît</au><au>Didier, Alain</au><au>Ameille, Jacques</au><au>Godard, Philippe</au><au>the group of experts</au><aucorp>French Society of Allergology and Clinical Immunology</aucorp><aucorp>French Speaking Pneumology Society</aucorp><aucorp>Asthma-Allergy association</aucorp><aucorp>French Society of Occupational Medicine</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Asthma and allergy: Short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the “Asthma–Allergy” association</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2008-10-01</date><risdate>2008</risdate><volume>102</volume><issue>10</issue><spage>1483</spage><epage>1493</epage><pages>1483-1493</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Summary The Asthma Plan published by the French Health Ministry in 2002, the experts conferences edited by ANAES on therapeutic education and follow-up of asthma, the inclusion of this disease in the Public Health Law have been remarkable steps in France during the last few years. The medical community, more particularly the pneumological community, has shown its commitment in the treatment of this public health problem. But allergy was not sufficiently taken into account, although it is responsible for nearly 50 to 60% cases of asthma. In most so-called developed countries the prevalence of asthma and of allergies has increased in the last twenty years. Its progress varies according to country and age group: the increased prevalence of allergy, more specifically of rhinitis and eczema, is most marked in children aged 6-7 year. The prevalence of asthma seems to have reached a plateau in certain northern countries or seems to have decreased in 13-14 year olds (Anglo-Saxon countries). There were multiple reasons, generally attributed to changes in life-style. Asthma is the result of an interaction between a genetic predisposition and the environment, where allergens are present, but also smoking. The relationships between allergy and asthma are complex. This conference discussed the various essential issues that face doctors who treat patients with asthma in their daily practice. The risk factors, the methods of exploration in children and adults and the specific treatments are, indeed, essential issues to be evaluated in a frequent pathology that interests a large number of physicians. The variety of experts is wide, representing pneumology (French Speaking Pneumology Society), the occupational medicine world (FrenchSociety of Occupational Medicine), the allergic pathology (French Society of Allergology and Clinical Immunology), and patients with the patient association “Asthma &amp; Allergy”, physicians belonging to the general medicine community, general hospitals, private hospitals and academic hospitals in France.The proposed guidelines are aimed at helping practitioners in distinguishing what is established from what remains to be demonstrated and/or assessed with respect to the different modalities for the exploration or treatment of allergic asthma.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>18640827</pmid><doi>10.1016/j.rmed.2008.03.002</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6111
ispartof Respiratory medicine, 2008-10, Vol.102 (10), p.1483-1493
issn 0954-6111
1532-3064
language eng
recordid cdi_proquest_journals_1035157235
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via ScienceDirect (Elsevier)
subjects Adult
Allergy
Anti-Allergic Agents - therapeutic use
Anti-Asthmatic Agents - therapeutic use
Asthma
Asthma - drug therapy
Asthma - immunology
Biological and medical sciences
Child
Chronic obstructive pulmonary disease, asthma
Exploration
France
Humans
Hypersensitivity - drug therapy
Hypersensitivity - immunology
Medical sciences
Occupational Medicine
Pneumology
Pulmonary Medicine
Pulmonary/Respiratory
Recommendations
Tobacco Smoke Pollution
title Asthma and allergy: Short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the “Asthma–Allergy” association
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T22%3A49%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Asthma%20and%20allergy:%20Short%20texts%20and%20recommendations%20of%20the%20expert%20conference%20of%20the%20French%20Speaking%20Pneumology%20Society%20(SPLF),%20in%20partnership%20with%20the%20French%20Society%20of%20Allergology%20and%20Clinical%20Immunology%20(SFAIC),%20the%20French%20Society%20of%20Occupational%20Medicine%20(SFMT)%20and%20the%20%E2%80%9CAsthma%E2%80%93Allergy%E2%80%9D%20association&rft.jtitle=Respiratory%20medicine&rft.au=Tillie-Leblond,%20Isabelle&rft.aucorp=French%20Society%20of%20Allergology%20and%20Clinical%20Immunology&rft.date=2008-10-01&rft.volume=102&rft.issue=10&rft.spage=1483&rft.epage=1493&rft.pages=1483-1493&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2008.03.002&rft_dat=%3Cproquest_cross%3E2745719621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035157235&rft_id=info:pmid/18640827&rft_els_id=1_s2_0_S095461110800098X&rfr_iscdi=true